By Dr. Shabnam Sarshar: Phytopharmacist, and Medical Advisor

Despite the explosion of Cannabis research sweeping through laboratories and clinics worldwide, one variable keeps reshaping the data yet remains astonishingly under‑acknowledged in mainstream practice: sex.

We’ve grown comfortable talking about strain versus dose, indica versus sativa, THC versus CBD, but when it comes to how Cannabis affects men and women differently, both consumers and clinicians are still largely in the dark. Yet the science is clear: sex matters: biologically, and behaviorally.

A growing body of research now shows that males and females diverge across almost every domain of Cannabis response, from how the body processes cannabinoids to how the mind interprets their effects. Understanding these sex-based differences isn’t just an academic exercise; it is the next frontier in designing equitable, effective, and safe Cannabis therapeutics.

Use Patterns: How Men and Women Actually Use Cannabis

Let’s start with real-world behavior.

Men still dominate Cannabis use overall. They tend to consume more frequently, prefer higher-potency products, and lean toward inhalation methods -think smoking or vaping- where rapid onset meets intensity.

Women, however, are swiftly closing this usage gap. When they do use Cannabis, their choices tell a different story. Women are more likely to reach for low-dose edibles, tinctures, or topicals. Many report using Cannabis for reasons beyond recreation (such as pain relief, stress reduction, support with sleep, or help with mood) and often describe stronger emotional and physical responses.

Women also report a higher likelihood of side effects like nausea, appetite changes, or anxiety. These subjective differences aren’t random or “in their head” they are grounded in biology.[1]

Metabolism and Hormones: The Chemistry of Difference

Women metabolize cannabinoids differently from men. Because women typically have a higher body fat composition, they store and release THC in distinct patterns, which can change both the intensity and duration of effects.[1]

The real twist, though, lies in how hormones interact with the endocannabinoid system. Estradiol, a key form of estrogen, doesn’t just shape reproductive biology. It also modulates CB1 receptors in the brain, which are central to Cannabis’s euphoric and rewarding effects.[1]

During high‑estradiol phases of the menstrual cycle, women may feel stronger effects from the same dose. That means the same gummy or vape hit could feel mild one week and overwhelming the next, depending on hormonal timing.[1]

This hormone–receptor dance cuts both ways: it can amplify therapeutic potential in some contexts, but also increase the risk of over‑activation, stronger side effects, or dependence. It is one reason why tracking menstrual phase in future clinical trials (and even in personal use diaries) really matters.

The Hidden Impact: Reproductive and Hormonal Health

Cannabis has earned attention for its versatility from pain and spasticity to anxiety and sleep, but it also interacts closely with the brain’s reproductive command center: the hypothalamic–pituitary–gonadal (HPG) axis. [2]

In females, THC can suppress the secretion of gonadotropin‑releasing hormone (GnRH), which then lowers luteinizing hormone (LH) levels, key signals for ovulation and healthy ovarian function. Over time, chronic Cannabis use may subtly influence menstrual patterns or fertility potential. [3]

In males, prolonged THC exposure can affect testosterone production, testicular function, and even sperm morphology and motility. These are not trivial side notes; they directly touch on fertility, vitality, and long‑term health. [4]

All of this has obvious implications for fertility counseling and preconception care. Yet most clinical workflows and guidelines still rarely mention Cannabis when discussing reproductive health, leaving both clinicians and patients with an important blind spot.

Addiction and Behavior: When the Brain Responds Differently

The conversation around Cannabis dependence is often painted with broad, gender‑neutral strokes, but the data tell a more nuanced story.

Research suggests that women may progress to dependence more rapidly and experience more severe withdrawal symptoms, including mood shifts, anxiety, and physical discomfort. They also report higher rates of anxiety and depression linked to Cannabis use.[1]

Men, by contrast, tend to show more prominent cognitive effects with repeated use: greater slowing in thinking, impaired decision‑making, and deficits in attention or certain types of memory. Both sexes can experience attention and memory issues, but the patterns and pathways differ.

Animal studies reinforce this picture. Female animals show heightened sensitivity to the rewarding and anxiety‑inducing effects of cannabinoids, largely driven by estradiol. This hormonal amplification helps explain why female humans may experience more intense motivational pulls, emotional highs, and emotional crashes with Cannabis use.[5]

Why This Matters: Science, Medicine, and Everyday Choices

These sex-based insights call for more than curiosity; they call for change. The Cannabis landscape is at a turning point, and “average user” thinking is no longer enough.

1. Research Design Needs a Revolution

Sex must be treated as a core biological variable, not a demographic afterthought. This means intentionally accounting for hormonal status, menstrual phase, and contraceptive use in women, and even androgen or fertility markers in men. Doing so sharpens data, reveals patterns currently hidden in the averages, and helps identify truly personalized therapeutic windows.

2. Clinical Practice Must Catch Up

Health professionals need tools for sex‑specific dosing, withdrawal management, and screening. Because women show heightened reward sensitivity and emotional impacts, clinicians might consider slower titration, more proactive monitoring of mood, or targeted counseling during high‑risk hormonal phases. At the same time, reproductive health discussions should routinely include Cannabis alongside alcohol, tobacco, and other commonly screened substances.

3. Public Health and Policy Should Reflect Reality

Educational campaigns and harm‑reduction messaging need to acknowledge that motivations, metabolism, and vulnerabilities differ by sex. Messages for women of reproductive age should include fertility and menstrual health considerations. For men, communication may also highlight cognitive and performance impacts. When information is tailored, it becomes more honest and more useful.

Moving Beyond “One‑Dose‑Fits‑All”

Cannabis affects male and female bodies in fundamentally distinct ways: biochemically, hormonally, and behaviorally. Ignoring these differences doesn’t just skew scientific results; it blurs patterns that could guide us toward safer, more effective, and more personalized therapies.

The Cannabis industry prides itself on precision: carefully curated varieties, specific cannabinoid ratios, sophisticated terpene profiles. Yet when it comes to the human side of the equation, conversations still often flatten complexity into a single “average user.”

By acknowledging sex as a key biological variable, we unlock the next chapter of Cannabis therapeutics: one rooted in personalized, evidence‑informed care. The future of Cannabis medicine won’t be one‑size‑fits‑all. It will be tuned to our biology, responsive to our hormones, and guided by science that finally sees both halves of the human equation.

Reference

1. Moser, A., Ballard, S. M., Jensen, J., & Averett, P. (2023). The influence of cannabis on sexual functioning and satisfaction. Journal of cannabis research, 5(1), 2. https://doi.org/10.1186/s42238-022-00169-2

2. Wesołowski, M., Sobaś, A., Biedka, K., Karwacki, J., Bulski, J., Błaszczyk, K., Żełabowski, K., Ziobro, O., Maj, F. J., Sornat, K., Estreicher, A., Klasa, A., Dłubak, A., & Sebzda, T. (2025). Effects of Phytocannabinoids on Reproductive System and Prenatal Development: Mechanisms and Clinical Implications. Journal of Clinical Medicine, 14(18), 6494. https://doi.org/10.3390/jcm14186494

3. Cameron, R. S., Perono, G. A., Natale, C. D., Petrik, J. J., Holloway, A. C., & Hardy, D. B. (2025). The impact of cannabinoids on reproductive function. Reproduction, 169(5), Article e240369, e240369. Retrieved Mar 4, 2026, from https://doi.org/10.1530/REP-24-0369

4. Lim J, Squire E, Jung KM. Phytocannabinoids, the Endocannabinoid System and Male Reproduction. World J Mens Health. 2023 Jan;41(1):1-10. https://doi.org/10.5534/wjmh.220132

5. Justin Matheson, Danial Behzad, Liisa A.M. Galea, and Patricia Di Ciano. 2026. Sex differences in the acute effects of cannabis: the need for hypothesis-driven research. Journal of Psychiatry and Neuroscience. 51: 1-8. https://doi.org/10.1139/jpn-2025-0164

About Dr. Shabnam Sarshar:

Dr. Shabnam Sarshar is a phytopharmacist and medical advisor specializing in Women’s Health, herbal medicine, and cannabinoid-based wellness solutions. Her work focuses on designing health strategies rooted in women’s biology, including menopause as biological recalibration, precision cannabinoid applications for female physiology, and hormone-aware leadership performance. She advises clinicians in developing evidence-based, physiology-driven solutions where medical Cannabis, phytotherapy, and lived experience align, advancing a model of care built around women’s biology rather than treating it as an afterthought.

Click the Learn More Button